Correlation Between Day One and Replimune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Replimune Group, you can compare the effects of market volatilities on Day One and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Replimune.

Diversification Opportunities for Day One and Replimune

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Day and Replimune is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Day One i.e., Day One and Replimune go up and down completely randomly.

Pair Corralation between Day One and Replimune

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.63 times more return on investment than Replimune. However, Day One Biopharmaceuticals is 1.59 times less risky than Replimune. It trades about 0.04 of its potential returns per unit of risk. Replimune Group is currently generating about 0.02 per unit of risk. If you would invest  1,063  in Day One Biopharmaceuticals on September 6, 2024 and sell it today you would earn a total of  317.00  from holding Day One Biopharmaceuticals or generate 29.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Replimune Group

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Replimune Group 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.

Day One and Replimune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Replimune

The main advantage of trading using opposite Day One and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.
The idea behind Day One Biopharmaceuticals and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Transaction History
View history of all your transactions and understand their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences